Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 5Brain Neoplasms 4Lymphoma 3Leukemia 3Glioblastoma 3Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioma 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Refractory Solid Tumors 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neurologic Manifestations 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms 1Mouth Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

Gemcitabine 9Paclitaxel 8Carboplatin 7atezolizumab 6Sunitinib 5navitoclax 4Topotecan 4Irinotecan 4Docetaxel 4Bevacizumab 4pazopanib 3liposomal doxorubicin 3cobimetinib 3Nivolumab 3Erlotinib Hydrochloride 3zolbetuximab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2temsirolimus 2selicrelumab 2plocabulin 2envafolimab 2darinaparsin 2brigimadlin 2adavosertib 2Tablets 2Sorafenib 2Rifampin 2RG7388 2Panitumumab 2NVP-BKM120 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Solid Tumors × Valproic Acid × Clear all
NCT00495872 2012-10-18

Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor

M.D. Anderson Cancer Center

Phase 1 Completed
204 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡